FDA Rejects Vanda Pharma's Application for Gastroparesis Drug Tradipitant
The Food and Drug Administration has turned away a proposed drug from Vanda Pharmaceuticals to treat the stomach disorder gastroparesis. Vanda on Thursday said the FDA has issued a so-called complete response letter for the drug,
With rising rates of obesity in the U.S. and increasing attention being paid to the health harms of processed foods, it's ...
Free COVID-19 test kits can be ordered by people across the U.S. starting at the end of the month to prepare for the ...
1d
The Food and Drug Administration (FDA) is looking to propose the inclusion of front-of-package warning labels that detail the ...
The Food and Drug Administration sends warning letters to entities under its jurisdiction as part of its enforcement ...
The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...
Three scientists are honored for developing a class of blockbuster weight-loss drugs. Is a Nobel prize on the way?
Zantac -- also known as ranitidine -- was a popular heartburn drug until 2020, when the Food and Drug Administration ordered it removed from pharmacy shelves because of a potential cancer risk ...
The Food and Drug Administration has approved Johnson & Johnson’s Tremfya (guselkumab) for the treatment of adults with ...
The US FDA has approved Kisqali (ribociclib) for treating early-stage breast cancer in combination with hormone therapy. It ...
Longboard Pharmaceuticals, Inc. (Nasdaq: LBPH), a clinical-stage biopharmaceutical company focused on developing novel, transformative medicines for neurological diseases, today announced that the FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback